SAAB AB ser. B (0GWL)
London Stock Exchange · UK · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 652.80 |
|---|---|
| 52-week range | 445.15 – 748.60 |
| Return, 1 month / 3 months | +5.0% / +9.7% |
| Return, 1 year / 3 years | +30.3% / +371.7% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 39.8% |
| Worst drawdown (1 year) | -32.8% |
| Average daily value traded | 124.05M SEK |
| Dividend yield | 0.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Saab AB is a Swedish defence and security company based in Stockholm. It designs and builds military aircraft, including the Gripen fighter, as well as submarines, surface vessels and combat vehicles. The company also supplies sensors, radar, missile systems, training equipment and command-and-control solutions. Its customers are mainly governments and armed forces, and it works with defence procurement agencies in Sweden and other countries. Saab also provides civil security and air traffic management products and support services.
The shares are listed on the London Stock Exchange in UK under the code 0GWL, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SAAB AB ser. B (0GWL) trades on the London Stock Exchange in UK. It last closed at SEK 652.80 on 27 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,218 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 30.3% and over the last three months it rose 9.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.5% | ||
| From 52-week high | -9.7% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 9.7% | ||
| 6-month return | 15.2% | ||
| 12-month return, skipping the last month | 24.1% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.8% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 124.05M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 23 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.4% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | +5.0% |
| 3 months | +9.7% |
| 6 months | +15.2% |
| 1 year | +30.3% |
| 3 years | +371.7% |
| 5 years | +1,106.6% |
Signals
| 50-day / 200-day average | 618.69 / 607.21 |
|---|---|
| Golden / death cross (60 days) | Golden, 43 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Oct 2026 | SEK 1.2000 |
| 2 Apr 2026 | SEK 1.2000 |
| 6 Oct 2025 | SEK 1.0000 |
| 11 Apr 2025 | SEK 1.0000 |
| 7 Oct 2024 | SEK 0.8000 |
| 12 Apr 2024 | SEK 12.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.